Peter Pellegrino, MD
Anesthesiology · Omaha, NENPI 1205320678
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (56.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 72.9% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $7,467 and has fallen 96.3% since, to $276 in 2025. Among anesthesiology clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 44 payments — averaging $201.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$6K
- Nevro Corp.$1K
- Abbott$331
- Saluda Medical Americas, Inc.$279
- Boston Scientific$242
- SPR Therapeutics, Inc$158
- plus $229 from 4 others
What the payments were for
- Grants$5,00056%
- Travel & lodging$1,04712%
- Food & beverage$2,06123%
- Education$7679%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 21 | $6,469 |
| Nevro Corp. | 8 | $1,166 |
| Abbott | 4 | $331 |
| Saluda Medical Americas, Inc. | 2 | $279 |
| Boston Scientific | 3 | $242 |
| SPR Therapeutics, Inc | 2 | $158 |
| Averitas Pharma Inc. | 1 | $122 |
| Vertex | 1 | $64 |
| Edwards Lifesciences | 1 | $25 |
| Nalu Medical, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$5,000
- VANTA ADAPTIVESTIM$961
- Omnia$767
- Evoke$279
- Senza$186
- ETERNA$158
- Intracept$138
- Qutenza$122
- PROCLAIM$115
How this compares
$8,874 in reported general payments places this provider in the 95th percentile of 281 anesthesiology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 67 | $1,264 |
| Pregabalin | 48 | $766 |
| Celecoxib | 20 | $607 |
| Gabapentin | 18 | $150 |
| Cyclobenzaprine Hcl | 17 | $57 |
| Alprazolam | 12 | $8 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Omaha
- Travis TeetorOmaha$82K
- Redgy FullerOmaha$9K
- Robert MuellemanOmaha$9K
- Kristina BirchOmaha$7K
- Michael LankhorstOmaha$6K
- Katherine McGuireOmaha$5K
- Kim Haynes-HensonOmaha$4K
- Christopher JodlowskiOmaha$3K
- Rafael Arsky LombardiOmaha$2K
- Carl HeineOmaha$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.